A20 regulates the therapeutic effect of anti-PD-1 immunotherapy in melanoma

BACKGROUND: The therapeutic effect of immune checkpoint blockers, especially the neutralizing antibodies of programmed cell death (PD-1) and its ligand programmed death ligand 1 (PD-L1), has been well verified in melanoma. Nevertheless, the dissatisfactory response rate and the occurrence of resista...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Weinan, Ma, Jinyuan, Guo, Sen, Wang, Huina, Wang, Sijia, Shi, Qiong, Liu, Lin, Zhao, Tao, Yang, Fengfan, Chen, Shuyang, Chen, Jianru, Zhao, Jianhong, Yu, Chen, Yi, Xiuli, Yang, Yuqi, Ma, Jingjing, Ni, Qingrong, Zhu, Guannan, Gao, Tianwen, Li, Chunying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733187/
https://www.ncbi.nlm.nih.gov/pubmed/33298620
http://dx.doi.org/10.1136/jitc-2020-001866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733187/
https://www.ncbi.nlm.nih.gov/pubmed/33298620
http://dx.doi.org/10.1136/jitc-2020-001866

Ejemplares similares